Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study

Abstract Aims Changes in echocardiographic parameters and biomarkers of cardiac and venous pressures or estimated plasma volume during hospitalization associated with decongestive treatments in acute heart failure (AHF) patients with either preserved left ventricular ejection fraction (LVEF) (HFPEF)...

Full description

Bibliographic Details
Main Authors:	Eiichi Akiyama, Raphaël Cinotti, Kamilė Čerlinskaitė, Lucas N.L. Van Aelst, Mattia Arrigo, Rui Placido, Tahar Chouihed, Nicolas Girerd, Faiez Zannad, Patrick Rossignol, Marc Badoz, Jean‐Marie Launay, Etienne Gayat, Alain Cohen‐Solal, Carolyn S.P. Lam, Jeffrey Testani, Wilfried Mullens, Gad Cotter, Marie‐France Seronde, Alexandre Mebazaa
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	ESC Heart Failure
Subjects:	Acute heart failure Congestion Biomarker Echocardiography Heart failure with preserved ejection fraction Heart failure with reduced ejection fraction
Online Access:	https://doi.org/10.1002/ehf2.12645

Similar Items

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
by: Giosafat Spitaleri, et al.
Published: (2022-01-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
by: Yifang GUO
Published: (2022-06-01)

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes
by: Mayu Tochiya, et al.
Published: (2023-04-01)

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry
by: Jeehoon Kang, et al.
Published: (2018-03-01)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
by: Lars H. Lund, et al.
Published: (2022-02-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
by: Timea Magdolna Szabo, et al.
Published: (2023-03-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Prevalence and Long‐Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction
by: Louise Y. Sun, et al.
Published: (2018-06-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction
by: Takahiro Jimba, et al.
Published: (2022-10-01)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
by: Marat Fudim, et al.
Published: (2021-11-01)

Similarities and Differences Between HFmrEF and HFpEF
by: Peixin Li, et al.
Published: (2021-09-01)

Heart failure with mid-range ejection fraction. Where are we today?
by: Tzvetana Katova
Published: (2021-07-01)

Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure
by: Patrick A. Gladding, et al.
Published: (2022-12-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
by: Marlies Antlanger, et al.
Published: (2017-04-01)

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction
by: Federico Ferro, et al.
Published: (2022-07-01)

Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
by: Ming-Jui Hung, et al.
Published: (2023-04-01)

A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis
by: Gaurav Panchal, et al.
Published: (2022-01-01)

Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure
by: Anupam Kumar, et al.
Published: (2019-02-01)

Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
by: Michael Lichtenauer, et al.
Published: (2021-05-01)

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction
by: Liam Gaziano, et al.
Published: (2021-12-01)

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
by: Bianca Dahlen, et al.
Published: (2021-06-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid‐range and preserved ejection fraction
by: Tomoya Ueda, et al.
Published: (2019-10-01)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
by: Michele Senni, et al.
Published: (2022-12-01)

Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge
by: Patrick Rossignol, et al.
Published: (2020-06-01)

Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease
by: Man Liu, et al.
Published: (2020-09-01)

Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
by: E. F. Pavlysh, et al.
Published: (2019-04-01)

Incidence, determinants, and outcomes of recovered left ventricular ejection fraction (LVEF) in patients with non-ischemic systolic heart failure; a hospital-based cohort study
by: Prakash Chand Negi, et al.
Published: (2023-03-01)

Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis
by: Elisabet Zamora, et al.
Published: (2022-12-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Tin‐Kwang Lin, et al.
Published: (2019-06-01)

Relationship Between Dietary Magnesium Intake and Incident Heart Failure Among Older Women: The WHI
by: Wen‐Chih Wu, et al.
Published: (2020-04-01)

Heart failure with preserved ejection fraction – new elements of evidence in the field of pathophysiology and new treatment options
by: Branimir Kanazirev
Published: (2021-07-01)

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research
by: Gad Cotter, et al.
Published: (2021-04-01)